Back to Trials
NCT03694691NARecruiting

Developing Viability Index for Machine Perfused Livers

Massachusetts General Hospital

Start Date

10/1/2018

Completion Date

6/1/2030

Summary

Machine perfusion technology is nearing the point of rescuing discarded liver grafts in the hope of proving them to be or improving them to the point of being transplantable. However, there are no validated metrics to determine transplantability after machine perfusion. This study involves collecting biopsies from transplanted livers before and after implantation to correlate metabolite and gene expression with post-transplant function. This data will help develop a viability index for machine perfused livers.

Eligibility Criteria

Age Range: 18 years to 75 years

Inclusion Criteria: * Male or female 18-75 years of age. * Candidate for a deceased-donor liver allograft. Exclusion Criteria: * Seropositivity for HIV-1.

Interventions

DIAGNOSTIC_TEST

Liver Biopsy

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Liver Cirrhoses

Locations

Massachusetts General Hospital

Boston, Massachusetts 02114

United States